Literature DB >> 16765411

Synthesis and differential antiproliferative activity of Biginelli compounds against cancer cell lines: Monastrol, oxo-monastrol and oxygenated analogues.

Dennis Russowsky1, Rômulo F S Canto, Sergio A A Sanches, Marcelo G M D'Oca, Angelo de Fátima, Ronaldo A Pilli, Luciana K Kohn, Márcia A Antônio, João Ernesto de Carvalho.   

Abstract

The synthesis and differential antiproliferative activity of monastrol (1a), oxo-monastrol (1b) and eight oxygenated derivatives 3a,b-6a,b on seven human cancer cell lines are described. For all evaluated cell lines, monastrol (1a) was shown to be more active than its oxo-analogue, except for HT-29 cell line, suggesting the importance of the sulfur atom for the antiproliferative activity. Monastrol (1a) and the thio-derivatives 3a, 4a and 6a displayed relevant antiproliferative properties with 3,4-methylenedioxy derivative 6a being approximately more than 30 times more potent than monastrol (1a) against colon cancer (HT-29) cell line.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765411     DOI: 10.1016/j.bioorg.2006.04.003

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  20 in total

1.  Synthesis and antitumoral activity of novel analogues monastrol-fatty acids against glioma cells.

Authors:  Franciele S De Oliveira; Patrick M De Oliveira; Luana M Farias; Rafael C Brinkerhoff; Rui Carlos M A Sobrinho; Tamara M Treptow; Caroline R Montes D'Oca; Marcelo A G Marinho; Mariana A Hort; Ana P Horn; Dennis Russowsky; Marcelo G Montes D'Oca
Journal:  Medchemcomm       Date:  2018-05-30       Impact factor: 3.597

2.  Antiproliferative activity of monastrol in human adenocarcinoma (MCF-7) and non-tumor (HB4a) breast cells.

Authors:  Lilian Areal Marques; Simone Cristine Semprebon; Andressa Megumi Niwa; Gláucia Fernanda Rocha D'Epiro; Daniele Sartori; Ângelo de Fátima; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-03       Impact factor: 3.000

3.  Nickel salt of phosphomolybdic acid as a bi-functional homogeneous recyclable catalyst for base free transformation of aldehyde into ester.

Authors:  Anjali Patel; Jay Patel
Journal:  RSC Adv       Date:  2020-06-09       Impact factor: 4.036

4.  Synthesis of novel perillyl-dihydropyrimidinone hybrids designed for antiproliferative activity.

Authors:  Vinicius Vendrusculo; Vanessa P de Souza; Luiz Antônio M Fontoura; Marcelo G M D'Oca; Thais P Banzato; Paula A Monteiro; Ronaldo A Pilli; João Ernesto de Carvalho; Dennis Russowsky
Journal:  Medchemcomm       Date:  2018-07-31       Impact factor: 3.597

Review 5.  Recent developments in the synthesis and applications of dihydropyrimidin-2(1H)-ones and thiones.

Authors:  Behzad Mohammadi; Farahnaz K Behbahani
Journal:  Mol Divers       Date:  2018-01-18       Impact factor: 2.943

6.  Vanillic aldehydes for the one-pot synthesis of novel 2-oxo-1,2,3,4-tetrahydropyrimidines.

Authors:  Jovana Muškinja; Nenad Janković; Zoran Ratković; Goran Bogdanović; Zorica Bugarčić
Journal:  Mol Divers       Date:  2016-01-30       Impact factor: 2.943

7.  Monastrol mimic Biginelli dihydropyrimidinone derivatives: synthesis, cytotoxicity screening against HepG2 and HeLa cell lines and molecular modeling study.

Authors:  Uttara Soumyanarayanan; Varadaraj G Bhat; Sidhartha S Kar; Jesil A Mathew
Journal:  Org Med Chem Lett       Date:  2012-06-12

8.  Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features.

Authors:  Bruna C Guido; Luciana M Ramos; Diego O Nolasco; Catharine C Nobrega; Bárbara Y G Andrade; Aline Pic-Taylor; Brenno A D Neto; José R Corrêa
Journal:  BMC Cancer       Date:  2015-04-14       Impact factor: 4.430

Review 9.  A mini-review on Biginelli adducts with notable pharmacological properties.

Authors:  Ângelo de Fátima; Taniris C Braga; Leonardo da S Neto; Bruna S Terra; Breno G F Oliveira; Daniel L da Silva; Luzia V Modolo
Journal:  J Adv Res       Date:  2014-11-01       Impact factor: 10.479

10.  Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents.

Authors:  Elena González-Hernández; Rubén Aparicio; Mercedes Garayoa; M José Montero; M Ángeles Sevilla; Concepción Pérez-Melero
Journal:  Medchemcomm       Date:  2019-07-04       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.